Breaking News Instant updates and real-time market news.

BIIB

Biogen

$340.67

-2.54 (-0.74%)

20:47
08/13/18
08/13
20:47
08/13/18
20:47

UK's NICE: Biogen's Spinraza too expensive for health service, Reuters reports

U.K.'s National Institute for Health and Care Excellence, or NICE, has ruled that Biogen's muscle disease treatment drug Spinraza, which has a list price of $750K in the first year of treatment, is too expensive for the nation's health service, Reuters reports, citing the agency's statement. NICE director Boysen said that the agency is "actively engaging with Biogen to discuss how they might address the uncertainties identified by the committee, while demonstrating the potential for nusinersen to be considered cost effective and managing the risk to the NHS of allowing access to this treatment." Reference Link

  • 13

    Aug

BIIB Biogen
$340.67

-2.54 (-0.74%)

08/01/18
PIPR
08/01/18
NO CHANGE
Target $400
PIPR
Overweight
Piper recommends Biogen shares after meeting with management
After hosting investor meetings with Biogen investor relations this week, Piper Jaffray analyst Christopher Raymond continues to recommend purchase of the shares. The analyst came away feeling like the "all-important" high-dose APOE4 subset analysis of the BAN2401 results "may be provided sooner than later." If shown to have little impact on the overall placebo-adjusted ADCOMS benefit, this should be an important event, Raymond tells investors in a research note. Coupling this with "continued solid commercial momentum and a host of other value-enhancing catalysts," the analyst continues to like the risk/reward on shares of Biogen. He keeps an Overweight rating on the name with a $400 price target.
08/01/18
08/01/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. JEFFERIES UPGRADES DROPBOX TO BUY: Jefferies analyst John DiFucci upgraded Dropbox (DBX) to Buy from Hold with an unchanged price target of $32. The analyst is not making a call on the Q2 results, which come on August 9. Rather, the upgrade is based "entirely on valuation," he stated. Dropbox is up 4.7% in late morning trading. JEFFERIES UPGRADES PAPA JOHN'S: Jefferies analyst Alexander Slagle upgraded Papa John's (PZZA) to Buy from Hold and raised his price target for the shares to $58 from $52. The stock, down 50% from highs, now reflects the likelihood that fundamentals will get worse before improving, Slagle said. After reviewing the company's potential path to recovery and possible strategic actions that could create shareholder value, the analyst has a bull case of $75 per share. He thinks this outweighs the bear case, or downside risk, of $35 per share. SAREPTA UPGRADED AFTER PULLBACK: Morgan Stanley analyst Matthew Harrison upgraded Sarepta Therapeutics (SRPT) to Overweight from Equal Weight, noting that the stock has given up much of the gains it saw when its initial DMD gene therapy data was announced. He sees the pullback as an opportunity to own the stock near pre-DMD gene therapy levels without taking the binary risk. He doesn't think a major bear case has emerged on the prospects for the company's DMD gene therapy program and he sees major catalysts in the second half of this year that he believes the market is missing. Harrison has a $163 price target on Sarepta shares. PIPER CUTS SHOPIFY TO NEUTRAL: Piper Jaffray analyst Michael Olson downgraded Shopify (SHOP) to Neutral from Overweight and lowered his price target to $145 from $155, saying that Shopify's Q2 was "good, but not good enough" with monthly recurring revenue below investor expectations. While Olson said Shopify is performing well, he believes their performance is mostly reflected in the stock's current valuation. PIPER RECOMMENDS BIOGEN AFTER MANAGEMENT MEETING: After hosting investor meetings with Biogen (BIIB) investor relations this week, Piper Jaffray analyst Christopher Raymond came away feeling like the "all-important" high-dose APOE4 subset analysis of the BAN2401 results "may be provided sooner than later." If shown to have little impact on the overall placebo-adjusted ADCOMS benefit, this should be an important event, Raymond said. Coupling this with "continued solid commercial momentum and a host of other value-enhancing catalysts," the analyst continues to like the risk/reward on Biogen. He kept an Overweight rating on shares with a $400 price target.
08/07/18
STFL
08/07/18
INITIATION
Target $394
STFL
Biogen resumed with a Buy at Stifel
Stifel analyst Paul Matteis resumed coverage of Biogen with a Buy rating and a $394 price target, citing his above consensus projections for Spinraza in Spinal Muscular Atrophy and his view that the odds of success for Aducanumab in Alzheimer's are "modestly better than 50/50." While there are real reasons to believe "this time is different" with Aducanumab, Matteis does worry that the floor value in a negative scenario for the Alzheimer's drug might be lower than some think, he tells investors.
08/07/18
STFL
08/07/18
INITIATION
Target $48
STFL
Hold
Ionis Pharmaceuticals transferred with a Hold at Stifel
Stifel transferred coverage of Ionis Pharmaceuticals (IONS) to analyst Paul Matteis, who set a Hold rating and $48 price target on the shares. The Biogen (BIIB) deal, while validating, limits some of the future upside for Ionis, Matteis tells investors. Also, despite his long-term bullishness on the TTR amyloidisis opportunity, he is below consensus for the first year of the launches for Tegsedi and Waylivra.

TODAY'S FREE FLY STORIES

SQ

Square

$68.82

1.12 (1.65%)

, TWTR

Twitter

$31.18

-1.08 (-3.35%)

13:45
01/23/19
01/23
13:45
01/23/19
13:45
Periodicals
Jack Dorsey tells Rolling Stone Square 'has to' run smoother than Twitter »

When Rolling Stone's…

SQ

Square

$68.82

1.12 (1.65%)

TWTR

Twitter

$31.18

-1.08 (-3.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 07

    Feb

  • 25

    Feb

  • 03

    Mar

GLNG

Golar LNG

$21.21

-0.75 (-3.42%)

13:45
01/23/19
01/23
13:45
01/23/19
13:45
Options
Golar LNG call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$31.16

-1.1 (-3.41%)

, SQ

Square

$68.86

1.16 (1.71%)

13:41
01/23/19
01/23
13:41
01/23/19
13:41
Periodicals
Twitter CEO tells Rolling Stone work on abuse 'needs to be done' »

Twitter (TWTR) and Square…

TWTR

Twitter

$31.16

-1.1 (-3.41%)

SQ

Square

$68.86

1.16 (1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 07

    Feb

  • 25

    Feb

  • 03

    Mar

CTGO

Contango Ore

$0.00

(0.00%)

13:32
01/23/19
01/23
13:32
01/23/19
13:32
Hot Stocks
Contango Ore starts process to solicit proposals for potential sale »

Contango ORE announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETFC

E-Trade

$49.05

-1.03 (-2.06%)

13:30
01/23/19
01/23
13:30
01/23/19
13:30
Options
Active trading in ETrade weekly options as shares fall ahead of earnings »

Active trading in ETrade…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 11

    Feb

AG

First Majestic

$5.25

0.08 (1.55%)

13:25
01/23/19
01/23
13:25
01/23/19
13:25
Options
First Majestic call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:20
01/23/19
01/23
13:20
01/23/19
13:20
General news
U.S. corporate bond update: ADB's $3.5 B 5-year headlines today »

U.S. corporate bond…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
01/23/19
01/23
13:17
01/23/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
01/23/19
01/23
13:16
01/23/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCL

Royal Caribbean

$107.77

-0.84 (-0.77%)

13:15
01/23/19
01/23
13:15
01/23/19
13:15
Options
Royal Caribbean put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JBHT

J.B. Hunt

$101.72

-2.03 (-1.96%)

13:12
01/23/19
01/23
13:12
01/23/19
13:12
Hot Stocks
J.B. Hunt raises quarterly dividend approx. 8.3% to 26c per share »

J.B. Hunt Transport…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:10
01/23/19
01/23
13:10
01/23/19
13:10
General news
Treasury Option Action: flows remain at low ebb »

Treasury Option Action:…

NTDOY

Nintendo

$0.00

(0.00%)

, TTWO

Take-Two

$101.62

-5.62 (-5.24%)

13:09
01/23/19
01/23
13:09
01/23/19
13:09
Periodicals
NPD says 'Smash Bros.' best-selling game in December in U.S., GI reports »

According to NDP Group,…

NTDOY

Nintendo

$0.00

(0.00%)

TTWO

Take-Two

$101.62

-5.62 (-5.24%)

ATVI

Activision Blizzard

$45.97

-1.07 (-2.27%)

EA

Electronic Arts

$89.46

-1.84 (-2.02%)

SNE

Sony

$48.27

-0.185 (-0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 05

    Feb

  • 06

    Feb

  • 12

    Feb

  • 25

    Feb

WBA

Walgreens Boots Alliance

$71.40

-0.19 (-0.27%)

13:07
01/23/19
01/23
13:07
01/23/19
13:07
Recommendations
Walgreens Boots Alliance analyst commentary  »

Walgreens already…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

TSLA

Tesla

$284.24

-14.56 (-4.87%)

13:04
01/23/19
01/23
13:04
01/23/19
13:04
Periodicals
Tesla scaled down Model S and X staff in recent layoffs, CNBC says »

According to a CNBC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

KCAP

KCAP Financial

$3.51

-0.05 (-1.40%)

13:01
01/23/19
01/23
13:01
01/23/19
13:01
Hot Stocks
Private Management Group reports 6.59% passive stake in KCAP Financial »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TIGO

Millicom

$62.07

-7.03 (-10.17%)

13:00
01/23/19
01/23
13:00
01/23/19
13:00
Hot Stocks
Gabelli says 'gotta buy' Millicom on today's selloff »

Mario Gabelli is speaking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$261.89

-1.165 (-0.44%)

13:00
01/23/19
01/23
13:00
01/23/19
13:00
Hot Stocks
Trump says will deliver SOTU address next week in House Chamber »

U.S. President Donald…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$261.89

-1.165 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTZ

MasTec

$43.51

-2.08 (-4.56%)

13:00
01/23/19
01/23
13:00
01/23/19
13:00
Options
Defensive option play in MasTec as shares drop almost 5% »

Defensive option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVNA

Carvana

$36.10

0.46 (1.29%)

, AN

AutoNation

$36.08

-0.96 (-2.59%)

12:58
01/23/19
01/23
12:58
01/23/19
12:58
Hot Stocks
Gabelli mentions Carvana, AutoNation as stock picks »

Mario Gabelli is speaking…

CVNA

Carvana

$36.10

0.46 (1.29%)

AN

AutoNation

$36.08

-0.96 (-2.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 29

    Jan

  • 22

    Feb

  • 27

    Feb

  • 27

    Feb

F

Ford

$8.32

-0.19 (-2.23%)

, GM

General Motors

$37.69

-0.49 (-1.28%)

12:58
01/23/19
01/23
12:58
01/23/19
12:58
Earnings
Fly Intel: What to watch in auto sector earnings reports »

Ford (F) is scheduled to…

F

Ford

$8.32

-0.19 (-2.23%)

GM

General Motors

$37.69

-0.49 (-1.28%)

VLKAY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 06

    Feb

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

GFF

Griffon

$12.99

-0.185 (-1.40%)

12:54
01/23/19
01/23
12:54
01/23/19
12:54
Hot Stocks
Breaking Hot Stocks news story on Griffon »

Griffon jumps 5% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$88.06

-0.2 (-0.23%)

12:53
01/23/19
01/23
12:53
01/23/19
12:53
Periodicals
Novartis preparing for 'doomsday' scenario in cancer treatment, BI reports »

Novartis is preparing for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSG

Madison Square Garden

$271.84

-2.105 (-0.77%)

12:52
01/23/19
01/23
12:52
01/23/19
12:52
Hot Stocks
Madison Square Garden shares could be worth as much as $350, Gabelli says »

Mario Gabelli is speaking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

GFF

Griffon

$13.01

-0.165 (-1.25%)

, ENR

Energizer

$45.35

0.07 (0.15%)

12:51
01/23/19
01/23
12:51
01/23/19
12:51
Hot Stocks
Griffon, Energizer mentioned as stock picks by Mario Gabelli »

Mario Gabelli is speaking…

GFF

Griffon

$13.01

-0.165 (-1.25%)

ENR

Energizer

$45.35

0.07 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.